Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Combination of Valsartan 320 mg Plus Hydrochlorothiazide 12.5 mg and Valsartan 320 mg Plus Hydrochlorothiazide 25 mg to Valsartan 320 mg in Mild to Moderate Hypertensive Patients Not Adequately Controlled With Valsartan 320 mg

NCT00170989 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00170989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00170989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Combination of Valsartan 320 mg Plus Hydrochlorothiazide 12.5 mg and Valsartan 320 mg Plus Hydrochlorothiazide 25 mg to Valsartan 320 mg in Mild to Moderate Hypertensive Patients Not Adequately Controlled With Valsartan 320 mg
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2004
Completion date
July 31, 2005
Enrollment
2,714 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension